EntryPoint Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
EntryPoint Capital's BIIB Position: Q2 2026 in Review
EntryPoint Capital opened a new position in Biogen (BIIB) in Q2 2026: 1,716 shares worth $371K. The stake represents 0.09% of the portfolio and ranks #452 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in BIIB as recently as Q3 2025.
EntryPoint Capital first reported a position in BIIB in Q1 2024 and has held it in 7 quarters since. The position peaked at $465K in Q3 2025. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- EntryPoint Capital held 1,716 shares of Biogen worth $371K as of Q2 2026.
- Biogen was a new EntryPoint Capital position in Q2 2026.
- Biogen made up 0.09% of EntryPoint Capital's portfolio in Q2 2026, its #452 holding.
- EntryPoint Capital first reported a position in Biogen in Q1 2024 and has held it in 7 quarters since.
- EntryPoint Capital's Biogen position peaked at $465K in Q3 2025.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.